Estrella Immunopharma (ESLA)
NASDAQ:ESLA
US Market
Holding ESLA?
Track your performance easily

Estrella Immunopharma (ESLA) Cash flow

22 Followers

Estrella Immunopharma Cash Flow

ESLA's free cash flow for Q was $―. For the fiscal year, ESLA's free cash flow was decreased by $-15.02M and operating cash flow was $-15.78M. See a summary of the company’s cash flow.
Cash Flow
TTM
Jun 24Dec 22Dec 21
Operating Cash Flow
$ -27.53M$ -16.07M$ -1.04M$ -316.16K
Investing Cash Flow
$ 9.94M$ 4.96M$ 36.17M$ -45.19M
Financing Cash Flow
$ 26.41M$ 12.79M$ -35.56M$ 45.98M
Cash Flow From Discontinued Operation
----
Other Cash Adjustment Inside Changein Cash
----
End Cash Position
$ 35.95M$ 4.17M$ 40.80K$ 478.87K
Income Tax Paid Supplemental Data
-$ 1.60K--
Interest Paid Supplemental Data
$ 5.33K$ 2.66K--
Issuance Of Capital Stock
---$ 3.15M
Issuance Of Debt
$ 20.14M$ 10.00M--
Repayment Of Debt
-$ -300.00K-$ -300.00K
Free Cash Flow
$ -487.86K$ -16.07M$ -1.04M$ -316.16K
Domestic Sales
----
Foreign Sales
----
Currency in USD

Estrella Immunopharma Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis